BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 8600488)

  • 1. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors.
    Skop BP; Brown TM
    Psychosomatics; 1996; 37(1):12-6. PubMed ID: 8600488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects.
    Stahl SM
    J Affect Disord; 1998 Dec; 51(3):215-35. PubMed ID: 10333979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs.
    Bismuth-Evenzal Y; Gonopolsky Y; Gurwitz D; Iancu I; Weizman A; Rehavi M
    J Affect Disord; 2012 Jan; 136(1-2):99-103. PubMed ID: 21893349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differential features of SSRIs].
    Cervera S
    Rev Med Univ Navarra; 1997; 41(4):245-57. PubMed ID: 10420965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms.
    Andrade C; Sandarsh S; Chethan KB; Nagesh KS
    J Clin Psychiatry; 2010 Dec; 71(12):1565-75. PubMed ID: 21190637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do antidepressants affect serotonin receptors? The role of serotonin receptors in the therapeutic and side effect profile of the SSRIs.
    Goodwin GM
    J Clin Psychiatry; 1996; 57 Suppl 4():9-13. PubMed ID: 8636065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding and selective serotonin reuptake inhibitors in childhood and adolescence.
    Lake MB; Birmaher B; Wassick S; Mathos K; Yelovich AK
    J Child Adolesc Psychopharmacol; 2000; 10(1):35-8. PubMed ID: 10755580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrapyramidal symptoms with selective serotonin reuptake inhibitors.
    Arya DK
    Br J Psychiatry; 1994 Dec; 165(6):728-33. PubMed ID: 7881774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of serotonin reuptake inhibitors on hemostasis.
    Alderman CP; Seshadri P; Ben-Tovim DI
    Ann Pharmacother; 1996 Nov; 30(11):1232-4. PubMed ID: 8913401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selective serotonin reuptake inhibitor(SSRI)].
    Motohashi N
    Nihon Rinsho; 2001 Aug; 59(8):1519-22. PubMed ID: 11519151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review.
    Ramasubbu R
    J Clin Psychiatry; 2004 Dec; 65(12):1642-53. PubMed ID: 15641869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitors reduce P2Y12 receptor-mediated amplification of platelet aggregation.
    Tseng YL; Chiang ML; Lane HY; Su KP; Lai YC
    Thromb Res; 2013 Apr; 131(4):325-32. PubMed ID: 23490430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitors (SSRIs) in children and adolescents.
    Vitiello B
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):7-9. PubMed ID: 16553524
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluoxetine inhibition of 5-HT-potentiated platelet aggregation in whole blood.
    Bampalis VG; Khandoga AL; Siess W
    Thromb Haemost; 2010 Dec; 104(6):1272-4. PubMed ID: 20806122
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something?
    Serebruany VL
    Am J Med; 2006 Feb; 119(2):113-6. PubMed ID: 16443409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of the pharmacology of serotonin reuptake inhibitors.
    Warrington SJ
    Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():13-9. PubMed ID: 1484174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical profile of YM992, a novel selective serotonin reuptake inhibitor with 5-HT2A receptor antagonistic activity.
    Hatanaka K; Nomura T; Hidaka K; Takeuchi H; Yatsugi S; Fujii M; Yamaguchi T
    Neuropharmacology; 1996; 35(11):1621-6. PubMed ID: 9025110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are the antiplatelet and profibrinolytic properties of selective serotonin-reuptake inhibitors relevant to their brain effects?
    Hoirisch-Clapauch S; Nardi AE; Gris JC; Brenner B
    Thromb Res; 2014 Jul; 134(1):11-6. PubMed ID: 24661990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of selective serotonin reuptake inhibitors on platelet function in whole blood and platelet concentrates.
    Reikvam AG; Hustad S; Reikvam H; Apelseth TO; Nepstad I; Hervig TA
    Platelets; 2012; 23(4):299-308. PubMed ID: 22273511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fluoxetine treatment on carbohydrate metabolism in human blood platelets: a 1H-NMR study.
    Tassini M; Vivi A; Gaggelli E; Valensin G; Laghi Pasini F; Puccetti L; Di Perri T
    Arch Biochem Biophys; 2002 Aug; 404(1):163-5. PubMed ID: 12127081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.